Market Overview:
The global medical and physical examination market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of chronic diseases, rising geriatric population, and technological advancements in diagnostic equipment. In addition, the growing demand for preventive healthcare services is also contributing to the growth of this market. Based on type, the medical and physical examination market can be segmented into prescription drugs and over-the-counter (OTC) drugs. The prescription drug segment is expected to grow at a higher CAGR than the OTC drug segment during the forecast period. This growth can be attributed to factors such as increasing prevalence of chronic diseases and technological advancements in diagnostic equipment that are resulting in more accurate diagnosis of diseases. Based on application, the medical and physical examination market can be divided into cardiovascular disease, tumor diagnosis, respiratory system disease diagnosis, other applications (such as neurology), and diagnostics testing services (such as pathology). The cardiovascular disease application segment is expected to account for a major share of this market during the forecast period owing to an increase in cases of heart attacks & strokes globally.
Product Definition:
A medical examination is a process by which a health care professional examines the body of a patient for signs of disease or injury. A physical examination, on the other hand, is an overall evaluation of a person's health and well-being. It includes inspecting all body systems and organs, as well as taking vital signs such as blood pressure and heart rate.
Prescription Drug:
Prescription drug is a medical device or pharmaceutical that is prescribed by doctors to treat a disease or condition. It's main function is to cure the disease and reduce the symptoms, but some prescription drugs have other functions as well such as they help with pain management. The most commonly used prescription drugs are analgesics which are pain relief medicines and anti-inflammatory drugs which reduce swelling caused by injury or inflammation.
OTC:
OTC is the Oh-so-terrible term used for medicines and other products that can be purchased without a prescription. OTC usually refers to medicines or medical devices that are available over the counter, such as vitamins, cough syrups, and antiseptics. These products do not require a prescription because they are considered safe for consumption in any amount.
Application Insights:
The global medical and physical examination market is segmented by application into the cardiovascular, tumor, respiratory system, and others. The cardiovascular segment dominated the overall market in terms of revenue share in 2017. This can be attributed to a high prevalence of cardiac diseases coupled with rising awareness about early diagnosis among patients. For instance, according to the CDC around 1 in every 3 deaths occur due to CVDs globally which accounts for around 2/3rds of all deaths worldwide.
Tumor was estimated as the second largest application segment owing to increasing incidence rate of cancer across various parts of world coupled with growing demand for diagnostic tests that help determine cause & treatment related information regarding tumorigenesis and metastasis at an early stage during clinical trials or before any other treatments are initiated thus contributing towards growth rate estimation.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to various factors such as high prevalence of chronic diseases, presence of sophisticated healthcare infrastructure and high patient awareness levels coupled with relatively higher health expenditure levels in this region as compared to other regions. In addition, an increasing number of international medical tourism due to availability of affordable treatment options is also expected to drive the demand for GMPE services over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising geriatric population and improving economic conditions leadingto a rise in disposable income which will enable more people access medical care facilities such as Global Medical & Physical Examination (GMPE). Moreover, government initiatives promoting healthy lifestyles are expected boost demand for GMPE services over next eight years. For instance, The National Health Promotion Foundation (NHPF) introduced by Ministry Of Health And Family Welfare India promotes overall wellbeing through promotion of physical activity against unhealthy eating habits thereby contributing towards market growth across Asia Pacific region.
Growth Factors:
- Increasing incidence of lifestyle diseases such as obesity, diabetes, and heart disease is expected to drive the demand for medical and physical examination services.
- Rising awareness about the benefits of early diagnosis is anticipated to boost the market growth.
- Growing geriatric population is likely to fuel the demand for preventive health check-ups and diagnostic services over the forecast period.
- Technological advancements in medical imaging and laboratory diagnostics are projected to create new opportunities for market players in medical and physical examination market during forecast period 2017-2025 . 5) increasing healthcare expenditure by governments across various countries is expected to provide impetus to market growth over next few years
Scope Of The Report
Report Attributes
Report Details
Report Title
Medical and Physical Examination Market Research Report
By Type
Prescription Drug, OTC
By Application
Cardiovascular, Tumor, Respiratory System, Other
By Companies
Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, Yunnan Baiyao, Tasly Holding Group, Bionorica Se, Huarun 999, Taiji, Weleda, Kwangdong, GW Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
203
Number of Tables & Figures
143
Customization Available
Yes, the report can be customized as per your need.
Global Medical and Physical Examination Market Report Segments:
The global Medical and Physical Examination market is segmented on the basis of:
Types
Prescription Drug, OTC
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cardiovascular, Tumor, Respiratory System, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Buchang Pharmaceuticals
- China TCM
- Tsumura
- Schwabe
- Tong Ren Tang
- Jumpcan Pharmaceutical
- Guangzhou Baiyunshan Pharmaceutical
- Yunnan Baiyao
- Tasly Holding Group
- Bionorica Se
- Huarun 999
- Taiji
- Weleda
- Kwangdong
- GW Pharmaceuticals
Highlights of The Medical and Physical Examination Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Prescription Drug
- OTC
- By Application:
- Cardiovascular
- Tumor
- Respiratory System
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Medical and Physical Examination Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A medical and physical examination is a routine health check that is typically done by a doctor. It includes checking the patient's vital signs, such as blood pressure and heart rate, and examining their body for any abnormalities. The doctor may also ask about the patient's symptoms and history.
Some of the major companies in the medical and physical examination market are Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, Yunnan Baiyao, Tasly Holding Group, Bionorica Se, Huarun 999, Taiji, Weleda, Kwangdong, GW Pharmaceuticals.
The medical and physical examination market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Medical and Physical Examination Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Medical and Physical Examination Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Medical and Physical Examination Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Medical and Physical Examination Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Medical and Physical Examination Market Size & Forecast, 2020-2028
4.5.1 Medical and Physical Examination Market Size and Y-o-Y Growth
4.5.2 Medical and Physical Examination Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Prescription Drug
5.2.2 OTC
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Cardiovascular
6.2.2 Tumor
6.2.3 Respiratory System
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Medical and Physical Examination Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Medical and Physical Examination Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Prescription Drug
9.6.2 OTC
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Cardiovascular
9.10.2 Tumor
9.10.3 Respiratory System
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Prescription Drug
10.6.2 OTC
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Cardiovascular
10.10.2 Tumor
10.10.3 Respiratory System
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Prescription Drug
11.6.2 OTC
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Cardiovascular
11.10.2 Tumor
11.10.3 Respiratory System
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Prescription Drug
12.6.2 OTC
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Cardiovascular
12.10.2 Tumor
12.10.3 Respiratory System
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Prescription Drug
13.6.2 OTC
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Cardiovascular
13.10.2 Tumor
13.10.3 Respiratory System
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Medical and Physical Examination Market: Competitive Dashboard
14.2 Global Medical and Physical Examination Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Buchang Pharmaceuticals
14.3.2 China TCM
14.3.3 Tsumura
14.3.4 Schwabe
14.3.5 Tong Ren Tang
14.3.6 Jumpcan Pharmaceutical
14.3.7 Guangzhou Baiyunshan Pharmaceutical
14.3.8 Yunnan Baiyao
14.3.9 Tasly Holding Group
14.3.10 Bionorica Se
14.3.11 Huarun 999
14.3.12 Taiji
14.3.13 Weleda
14.3.14 Kwangdong
14.3.15 GW Pharmaceuticals
